Oncology 4 (Mast Cell Tumor)

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/51

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

52 Terms

1
New cards

Mast cell tumors are called the ____ !

great imitator — because they can look like anything and have a wide range of biologic behavior

<p>great imitator — because they can look like anything and have a wide range of biologic behavior</p>
2
New cards

How common are MCT?

Most common cutaneous tumor in dogs (16-21%)

3
New cards

What is the signalment (age, breeds) associated with MCT?

~9 yo

Boxers, boston terriers, Labs, pugs, bulldogs, mixed

4
New cards

What type of cells are mast cells and where are they found normally?

round cells

normally in lungs, liver, skin, GI, lymphoid tissue

<p>round cells</p><p>normally in lungs, liver, skin, GI, lymphoid tissue</p>
5
New cards

What are the roles of mast cells?

wound healing, induction of innate immune response, anti-parasitic activity

<p>wound healing, induction of innate immune response, anti-parasitic activity</p>
6
New cards

Mast cell granules contain _________ which causes _______.

- heparin, histamine, proteases, preformed TNF-alpha

- vasodilation, vascular leakage, smooth muscle constriction

<p>- heparin, histamine, proteases, preformed TNF-alpha</p><p>- vasodilation, vascular leakage, smooth muscle constriction </p>
7
New cards

How do MCT lesions present clinically?

  • most are cutaneous or subcutaneous

  • most are solitary (11-14% of dogs multiple lesions)

  • majority located on trunks or limbs 

8
New cards

True or False? MCT only present cutaneously.

False. There is a visceral form (disseminated or systemic mastocytosis) and primary GI form which is rare.

9
New cards

What is the patient history like in MCT?

  • mass “comes and goes” or “appeared overnight”

  • redness, swelling, pain

  • Darier’s sign = local degranulation from mast cell degranulation after manipulation 

  • More rarely → v/d, fever, collapse 

10
New cards

What is the etiology of MCT?

mostly unknown, multiple genetic links under investigation

suspected receptor tyrosine kinase (RTK) KIT

11
New cards

RTKs convey ___ signals from outside the cell to inside the cell.

growth factor

12
New cards

What is c-kit?

proto-oncogene that encodes for KIT (a RTK) 

13
New cards

___ binds to KIT to promote ___, ___, ___ of normal mast cells.

Stem cell factor (SCF),

proliferation, differentiation, maturation

14
New cards

How are MCT and c-kit associated?

20-30% of grade 2/3 tumors have an ACTIVATING mutation of c-kit

→ SCF-independent activation of KIT → upregulation of signal transduction

15
New cards

c-kit mutation is linked to _____

increased risk of local reoccurence, metastasis, and worse outcome in MCT 

16
New cards

Common mutation sites in c-kit?

Exons 11, 12 (juxtamembrane), and 8, 9 (extracellular).

17
New cards

What is the first-line diagnostic test for MCT?

Fine-needle aspiration (FNA) cytology.

18
New cards

What stains are best to visualize mast cell granules?

Giemsa or toluidine blue.

<p>Giemsa or toluidine blue.</p>
19
New cards

Why might granules not stain with Diff-Quik?

Mast cell granules may appear unstained with this method.

<p>Mast cell granules may appear unstained with this method.</p>
20
New cards

What should be administered before FNA a possible MCT?

Diphenhydramine (to reduce degranulation reactions).

<p>Diphenhydramine (to reduce degranulation reactions).</p>
21
New cards

What type of biopsy confirms diagnosis and grading of MCT?

Incisional or excisional biopsy with histopathology.

22
New cards

What are the five major prognostic factors for MCTs?

  1. Histologic grade,

  1. Stage,

  2. c-kit status,

  3. Proliferation rate,

  4. Other factors (breed, size, location).

23
New cards

What is the Patnaik grading system?

3-tier system: Grade 1 (low), Grade 2 (intermediate), Grade 3 (high).

<p>3-tier system: Grade 1 (low), Grade 2 (intermediate), Grade 3 (high).</p>
24
New cards

Median survival time (MST) for Grade 3 tumors?

~278 days (9.2 months)

25
New cards

MST for Grade 1–2 tumors?

> 3 years.

26
New cards

__ % of low or intermediate grade MCT resulted in death of patient.

15-30%

27
New cards

What is the Kiupel grading system?

2-tier system: Low grade (MST > 2 yrs), High grade (MST < 4 months).

<p>2-tier system: Low grade (MST &gt; 2 yrs), High grade (MST &lt; 4 months).</p>
28
New cards

Which organs are most commonly affected by metastasis?

Lymph nodes → spleen → liver (rarely lungs).

<p>Lymph nodes → spleen → liver (rarely lungs).</p>
29
New cards

How common is metastasis in high-grade MCTs?

55–96%

30
New cards

What staging tests are recommended?

LN FNA (sentinel lymph node mapping), abdominal ultrasound, liver/spleen aspirates, ± thoracic radiographs

<p>LN FNA (sentinel lymph node mapping), abdominal ultrasound, liver/spleen aspirates, ± thoracic radiographs</p>
31
New cards

What is the purpose of a buffy coat smear?

To check for circulating mast cells (though nonspecific) aka peripherla mastocytosis

32
New cards

What is the MCT Prognostic Panel used for?

Predicting biologic behavior, especially for intermediate-grade tumors.

BUT EXPENSIVE. 

Most helpful for grade 2/intermediate grade MCT or if behavior is in question 

<p>Predicting biologic behavior, especially for intermediate-grade tumors. </p><p>BUT EXPENSIVE.&nbsp;</p><p>Most helpful for grade 2/intermediate grade MCT or if behavior is in question&nbsp;</p>
33
New cards

What KIT IHC staining pattern indicates worse prognosis?

Diffuse cytoplasmic staining of CD117 (KIT).

34
New cards

What mitotic index indicates poor prognosis?

> 5 mitoses per HPF

35
New cards

What does increased Ki67 indicate?

Higher proliferation rate → worse prognosis.

36
New cards

What are the treatment modalities for MCT?

surgery, radiation, chemotherapy, or combination

<p>surgery, radiation, chemotherapy, or combination</p>
37
New cards

What is the treatment of choice for localized MCTs?

Wide surgical excision.

<p>Wide surgical excision.</p>
38
New cards

Recommended surgical margins for MCT?

2–3 cm lateral and 1 fascial plane deep.

<p>2–3 cm lateral and 1 fascial plane deep.</p>
39
New cards

What % of low/intermediate-grade MCT recur after surgery?

20–30%

40
New cards

When is radiation indicated for MCT?

When microscopic disease remains after surgery or re-excision is not possible.

<p>When microscopic disease remains after surgery or re-excision is not possible.</p>
41
New cards

When is chemotherapy used for MCT?

For high-risk, metastatic, or recurrent disease; as adjuvant therapy.

<p>For high-risk, metastatic, or recurrent disease; as adjuvant therapy.</p>
42
New cards

Common drugs used in MCT chemotherapy?

Vinblastine, Palladia, lomustine (CCNU), hydroxyurea, chlorambucil, vinorelbine ± prednisone.

<p>Vinblastine, Palladia, lomustine (CCNU), hydroxyurea, chlorambucil, vinorelbine ± prednisone.</p>
43
New cards

Typical chemotherapy response rate for gross MCT disease?

10–60%

44
New cards

What tyrosine kinase inhibitor is FDA-approved for canine MCT?

Toceranib phosphate (Palladia)

<p>Toceranib phosphate (Palladia)</p>
45
New cards

What pathways does Palladia inhibit?

VEGFR2, PDGFR, KIT

<p>VEGFR2, PDGFR, KIT</p>
46
New cards

Approximate overall response rate to Palladia?

60% (43% response + 17% stable disease)

<p>60% (43% response + 17% stable disease)</p>
47
New cards

What supportive medications can be considered?

Antihistamines, steroids 

<p>Antihistamines, steroids&nbsp;</p>
48
New cards

Which H1 blocker is recommended?

Diphenhydramine

49
New cards

Which H2 blocker is recommended?

Famotidine

Omeprazole (not a H2 blocker, PPI that is used also)

50
New cards

What steroid can help reduce tumor swelling and mast cell activity? How?

Prednisone

Inhibit MCT proliferation and induce apoptosis in vitro, may decrease peritumor edema clinically

<p>Prednisone</p><p>Inhibit MCT proliferation and induce apoptosis in vitro, may decrease peritumor edema clinically</p>
51
New cards

Prednisone response rate for intermediate/high-grade MCT as a single-agent?

~24%, short duration (weeks)

<p>~24%, short duration (weeks)</p>
52
New cards

When should you consider supportive treatments with MCT?

if P has gross disease or as part of chemo protocol